Grants and Contributions:

Back to search
Title:
Operating Grant: TRANSCAN-3
Agreement Number:
168189
Agreement Value:
$270,250.00
Agreement Date:
Oct 1, 2022 - Sep 30, 2025
Description:
The specific objective of this funding opportunity is: to improve the efficacy of personalized treatment of cancer patients through the development of new tools and targeted immunotherapy strategies, based on a better understanding of TME functions and of their impact on the disease course.
Organization:
Canadian Institutes of Health Research
Expected Results:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.

Location:
Montreal, Quebec, CA H3A 0G4
Reference Number:
236-2022-2023-Q3-00572
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Recipient's Legal Name:
Quail, Daniela
Research Organization:
McGill University|Université McGill
Program:
Research in Priority Areas
Program Purpose:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.